Advertisement
LabX
LabX

The Scientist

» pharmaceuticals

Most Recent

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Opinion: Reasons for the R&D Crisis

Opinion: Reasons for the R&D Crisis

By | September 23, 2013

Response to an opinion in The Scientist charting current pitfalls in translational research

2 Comments

image: Pharma Moves Toward Transparency

Pharma Moves Toward Transparency

By | July 29, 2013

The pharmaceutical industry has agreed to share data from clinical trials with researchers, patients, and the public.

0 Comments

image: Misconduct Delayed Drug Approval

Misconduct Delayed Drug Approval

By | July 10, 2013

FDA endorsement of a new blood-thinning drug was held back for almost a year because the agency discovered misconduct at clinical trial sites in China.  

2 Comments

image: NIH to Resurrect Old Drugs

NIH to Resurrect Old Drugs

By | June 20, 2013

Academic scientists and the pharmaceutical industry will collaborate on a new program to speed up the drug development process.

0 Comments

image: Top GSK Scientist Fired Over Paper

Top GSK Scientist Fired Over Paper

By | June 19, 2013

The head of GlaxoSmithKline’s Shanghai neurodegenerative-disease research unit is axed after irregularities are uncovered in a 2010 paper he published.

0 Comments

image: Release of Drug Data Blocked

Release of Drug Data Blocked

By | May 2, 2013

A court ruling that stops the European Medicines Agency from releasing data from two US companies calls into question the agency’s push for transparency.

0 Comments

image: AstraZeneca Downsizing R&D Staff

AstraZeneca Downsizing R&D Staff

By | March 19, 2013

Positions for 1,600 scientists at the pharmaceutical company will be eliminated globally.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

Advertisement

Popular Now

  1. Antibody Maker Loses License Over Animal Welfare Violations
  2. ORI: Researcher Faked Dozens of Experiments
    The Nutshell ORI: Researcher Faked Dozens of Experiments

    A former scientist at the University of Michigan and the University of Chicago made up more than 70 experiments on heart cells, according to the Office of Research Integrity.

  3. Exploring Emotional Contagion
  4. Immune Defect Detected in Knockout Mice
Advertisement
LabX
LabX
Advertisement
Biosearch Technologies
illumina Corporate
illumina Corporate